Business Wire

SPIE, the International Society for Optics and Photonics, Announces Its 2026 Society Awards

8.1.2026 18:26:00 CET | Business Wire | Press release

Share

The 22 award recipients represent an exciting range of stellar achievements across light-based sciences and technologies

Today, the Awards Committee of SPIE, the international society for optics and photonics, announced the recipients of its prestigious annual awards. Honoring transformative advancements across a range of professional areas — including medicine, astronomy, lithography, optical metrology, optical design, and community leadership — the Society's awards recognize technical accomplishments as well as committed service to SPIE and support of its organizational mission.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108227351/en/

SPIE, the international society for optics and photonics, awarded their Gold Medal to Maryellen Giger (pictured here with her team) for pioneering work in computer-aided diagnosis and image analysis/AI, significant impact on clinical translation, and supporting the next generation of medical-imaging scientists and the SPIE community.

SPIE Gold Medal: Maryellen Giger
For pioneering work in computer-aided diagnosis and image analysis/AI, significant impact on clinical translation, and supporting the next generation of medical-imaging scientists and the SPIE community.

SPIE President's Award: James Sydor
For visionary leadership, philanthropy, and service to SPIE and the precision optics community through advancements in optical fabrication, support of optics education, and professional training of current and future technicians.

SPIE Directors' Award: Xiao-Cong (Larry) Yuan and Anatoly Zayats
For exceptional leadership in founding the high-impact journal Advanced Photonics as co-editor-in-chiefs. Since 2019, the journal has showcased innovative research and raised the prestige of SPIE publishing.

SPIE Mozi Award: Hui Cao
For pioneering work in novel light sources, and demonstrating a wide range of applications in imaging, sensing, and random number generation.

SPIE Aden and Marjorie Meinel Technology Achievement Award: Sos Agaian
For pioneering contributions to computational perception-based image processing, particularly in blind image quality assessment and randomness measurement, leading to significant advancements in image editing and medical imaging.

SPIE A.E. Conrady Award in Optical Engineering: Ching-Cherng Sun
For outstanding optical engineering contributions in the advancement of design, development, and testing of solid-state LED lighting.

SPIE Biophotonics Technology Innovator Award: Jürgen Popp
For contributions to the clinical translation of Raman spectroscopy, enabling real-time, label-free diagnostics in oncology and infectious disease, and advancing biophotonics from concept to clinical application.

SPIE Britton Chance Biomedical Optics Award: Irving Bigio
For pioneering elastic scattering spectroscopy and translating it into a clinically impactful diagnostic tool, and for mentoring a generation of leaders in translational biomedical optics.

SPIE Chandra S. Vikram Award in Optical Metrology: James Burge
For lifetime achievement in optical metrology with astronomical instrumentation innovations, technology commercialization, and career-long mentorship, guidance, and team-building in the precision optics and astronomy communities.

SPIE Dennis Gabor Award in Diffractive Optics: Shin-Tson Wu
For pioneering contributions to large-angle liquid crystal polarization volume gratings and their widespread applications for augmented reality and virtual reality displays.

SPIE Diversity Outreach Award: Kimani Toussaint
For the promotion of inclusion, diversity, and equity in the development of biomedical diagnostics, in optics research and mentoring, and in public outreach and awareness.

SPIE Early Career Achievement Award — Academic Focus: Alex Walsh
For innovations in label-free optical microscopy through integration of fluorescence lifetime imaging and machine learning, and for outstanding mentorship and service contributions within the community.

SPIE Early Career Achievement Award — Industry/Government Focus: Amirhossein Ghods
For pioneering manufacturable, next-generation VCSEL platforms that advance quantum, biomedical, and dual-use sensing across industry and defense.

SPIE Frits Zernike Award for Microlithography: Andreas Erdmann
For contributions to the understanding and modeling of image formation and resist patterning in deep and EUV lithography, especially photomasks’ 3D effect, and for lithography education.

SPIE G. G. Stokes Award in Optical Polarization: Siddharth Ramachandran
For seminal contributions in the area of spatially and vectorially structured light in optical fibers.

SPIE Harold E. Edgerton Award in High-Speed Optics: Peter Delfyett
For pioneering contributions to the field of low-noise, high-power, ultrafast semiconductor lasers and their commercial applications.

SPIE Harrison H. Barrett Award in Medical Imaging: Norbert Pelc
For defining the fields of X-ray, CT, and MR imaging for over 40 years, impacting clinical care, and inspiring, nurturing, and encouraging generations of clinicians and scientists.

SPIE Maiman Laser Award: Edik Rafailov
For pioneering contributions to high-power aluminum-free diode lasers and ultrafast quantum dot laser technology, and their transformative impact on non-linear optics and biomedical photonics.

SPIE Maria Goeppert Mayer Award in Photonics: Carmen Menoni
For pioneering innovations in extreme ultraviolet photonics, the research and development of advanced amorphous oxide coatings for laser science, and community leadership.

SPIE María J. Yzuel Educator Award: Bahaa Saleh
For significant contributions to education in optics, photonics, and image science.

SPIE George W. Goddard Award in Space and Airborne Optics: Lee Feinberg
For outstanding leadership through the design, integration, and delivery of optical systems that brought the objectives of the Webb and Hubble space telescopes into clear focus.

The complete listing of the SPIE Society Awards and their recipients is available here.

About SPIE

SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, we have invested more than $26 million in the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260108227351/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release

The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye